NeurosciencebioRxivPreprint
Phenotypic screening in Parkinson's iPSC-dopamine neurons identifies the FASN-SREBP1 axis as a potential therapeutic target
Maria Claudia Caiazza, Janine Brandes, Elizabeth R. Barrow…·Richard Wade‐Martins
The paper uses patient-derived iPSC-dopamine neurons to screen compounds and identifies the FASN-SREBP1 axis as a potential therapeutic target for Parkinson's disease.
DOI 10.64898/2026.10.27.761977